Correlation Between Amylyx Pharmaceuticals and Arvinas

Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Arvinas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Arvinas into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amylyx Pharmaceuticals and Arvinas, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Arvinas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Arvinas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Arvinas.

Diversification Opportunities for Amylyx Pharmaceuticals and Arvinas

-0.09

Correlation Coefficient

Amylyx Pharmaceuticals  Arvinas

Good diversification

The 3 months correlation between Amylyx and Arvinas is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Arvinas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arvinas and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Arvinas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arvinas has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Arvinas go up and down completely randomly.

Pair Corralation between Amylyx Pharmaceuticals and Arvinas

Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 0.61 times more return on investment than Arvinas. However, Amylyx Pharmaceuticals is 1.65 times less risky than Arvinas. It trades about 0.03 of its potential returns per unit of risk. Arvinas is currently generating about -0.14 per unit of risk. If you would invest  384.00  in Amylyx Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  3.00  from holding Amylyx Pharmaceuticals or generate 0.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Amylyx Pharmaceuticals  vs.  Arvinas

Amylyx Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Arvinas

Risk-Adjusted Performance

Very Weak

Over the last 90 days Arvinas has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Amylyx Pharmaceuticals and Arvinas

The main advantage of trading using opposite Amylyx Pharmaceuticals and Arvinas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Arvinas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will offset losses from the drop in Arvinas' long position.

The idea behind Amylyx Pharmaceuticals and Arvinas pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.